These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30178044)

  • 21. Assessment of cardiovascular and noncardiovascular medical device recalls.
    Somberg JC; McEwen P; Molnar J
    Am J Cardiol; 2014 Jun; 113(11):1899-903. PubMed ID: 24837271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Approaching Regulatory Approval of Cardiovascular Regenerative Therapy.
    Povsic TJ
    Circ Res; 2018 Feb; 122(4):552-554. PubMed ID: 29449363
    [No Abstract]   [Full Text] [Related]  

  • 23. Auditing device clinical studies for US requirements.
    Donawa M
    Med Device Technol; 2007 Oct; 18(6):24-7. PubMed ID: 18078178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physiologic monitoring devices.
    Alpert S
    Crit Care Med; 1995 Oct; 23(10):1626-7. PubMed ID: 7587226
    [No Abstract]   [Full Text] [Related]  

  • 25. What is involved in a regulatory trial investigating a new medical device?
    McKay PJ; Resendes S; Schemitsch E; Bhandari M
    J Long Term Eff Med Implants; 2007; 17(2):165-71. PubMed ID: 18540859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advocates call for FDA to take tougher stance on postmarket safety studies.
    Kuehn BM
    JAMA; 2011 Oct; 306(15):1639-40, 1642. PubMed ID: 22009087
    [No Abstract]   [Full Text] [Related]  

  • 27. Humanitarian Use Devices/Humanitarian Device Exemptions in cardiovascular medicine.
    Kaplan AV; Harvey ED; Kuntz RE; Shiran H; Robb JF; Fitzgerald P
    Circulation; 2005 Nov; 112(18):2883-6. PubMed ID: 16267261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular device development: an FDA perspective.
    Zuckerman BD; Muni NI
    Am J Ther; 2005; 12(2):176-8. PubMed ID: 15767836
    [No Abstract]   [Full Text] [Related]  

  • 29. Report from the meeting of the Circulatory System Devices Panel of the Food and Drug Administration Center for Devices and Radiologic Health: September 21, 2004.
    Maisel WH;
    Circulation; 2005 Apr; 111(16):2143-5. PubMed ID: 15851621
    [No Abstract]   [Full Text] [Related]  

  • 30. Advertising of therapies for cardiovascular patients.
    Foster MC
    Clin Cardiol; 1997 May; 20(5):506-7. PubMed ID: 9134288
    [No Abstract]   [Full Text] [Related]  

  • 31. An FDA Viewpoint on Unique Considerations for Medical-Device Clinical Trials.
    Faris O; Shuren J
    N Engl J Med; 2017 Apr; 376(14):1350-1357. PubMed ID: 28379790
    [No Abstract]   [Full Text] [Related]  

  • 32. US Food and Drug Administration medical device review and approval; myths, misconceptions, realities, and potential policy changes.
    Wallner PE; Sandler HM
    Pract Radiat Oncol; 2014; 4(6):472-8. PubMed ID: 25407871
    [No Abstract]   [Full Text] [Related]  

  • 33. Experience with reviewing Bayesian medical device trials.
    Pennello G; Thompson L
    J Biopharm Stat; 2008; 18(1):81-115. PubMed ID: 18161543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. So We Have Bioresorbable Scaffolds: Now What?
    King SB
    JACC Cardiovasc Interv; 2016 May; 9(10):1087-8. PubMed ID: 27198690
    [No Abstract]   [Full Text] [Related]  

  • 35. Relocating abroad. FDA sends staff overseas to help monitor imports.
    Lee J
    Mod Healthc; 2011 Oct; 41(43):32. PubMed ID: 22111150
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparative assessment for medications and devices: apples and oranges?
    Ramsey S
    Value Health; 2010 Jun; 13 Suppl 1():S12-4. PubMed ID: 20618788
    [No Abstract]   [Full Text] [Related]  

  • 37. What does "FDA Approved" mean for medical devices?
    Nygaard I
    Obstet Gynecol; 2008 Jan; 111(1):4-6. PubMed ID: 18165386
    [No Abstract]   [Full Text] [Related]  

  • 38. The Food and Drug Administration and atrial defibrillation devices.
    Chen L; Keane AT; Every NR
    Am J Manag Care; 1999 Jul; 5(7):899-909. PubMed ID: 10557410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Building comparative efficacy and tolerability into the FDA approval process.
    O'Connor AB
    JAMA; 2010 Mar; 303(10):979-80. PubMed ID: 20215612
    [No Abstract]   [Full Text] [Related]  

  • 40. Characterization and outcomes of reinterventions in Food and Drug Administration-approved versus trial endovascular aneurysm repair devices.
    Fairman AS; Wang GJ; Jackson BM; Foley PJ; Damrauer SM; Kalapatapu V; Golden MA; Fairman RM
    J Vasc Surg; 2018 Apr; 67(4):1082-1090. PubMed ID: 29074115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.